Last reviewed · How we verify

NCT04618445

Prevalence of Temporomandibular Joint Disorders Among Egyptian University Undergraduate Students

Status unknown Last updated 4 August 2021
What this trial tests

trial testing some risk factors that might be correlated with TMD in TMD in 1,000 participants. Status unknown.

Timeline
1 December 2020
Primary endpoint
1 August 2022
1 November 2022

Quick facts

Lead sponsorCairo University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 December 2020
Primary completion1 August 2022
Estimated completion1 November 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 45, any sex, with TMD or Bruxism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will take place in Egypt. Undergraduate students from different faculties of the Egyptian Universities will participate. The study began in December 2020.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for TMD

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04618445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing